Correlation Between Cingulate Warrants and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Connect Biopharma Holdings, you can compare the effects of market volatilities on Cingulate Warrants and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Connect Biopharma.

Diversification Opportunities for Cingulate Warrants and Connect Biopharma

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cingulate and Connect is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Connect Biopharma go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Connect Biopharma

Assuming the 90 days horizon Cingulate Warrants is expected to generate 14.31 times more return on investment than Connect Biopharma. However, Cingulate Warrants is 14.31 times more volatile than Connect Biopharma Holdings. It trades about 0.12 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about 0.04 per unit of risk. If you would invest  26.00  in Cingulate Warrants on September 5, 2024 and sell it today you would lose (21.15) from holding Cingulate Warrants or give up 81.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy74.95%
ValuesDaily Returns

Cingulate Warrants  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Connect Biopharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Cingulate Warrants and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Connect Biopharma

The main advantage of trading using opposite Cingulate Warrants and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind Cingulate Warrants and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.